| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.1M | -2.8% |
| R&D Expense | $10.4M | +43.7% |
| SG&A Expense | $4.9M | +4.4% |
| Operating Income | -$10.2M | -52.2% |
| Interest Expense | $6K | -27.9% |
| Net Income | -$10.2M | -27.4% |
| EPS (Basic) | -$3.98 | +65.2% |
| EPS (Diluted) | -$3.98 | +65.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | +23.1% |
| Current Assets | $7.2M | +35.5% |
| Total Assets | $7.5M | +33.1% |
| Current Liabilities | $4.6M | +106.9% |
| Total Liabilities | $4.6M | +106.0% |
| Stockholders' Equity | $3.2M | -13.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.8M | -4.0% |
| Capital Expenditures | $124K | — |
| Investing Cash Flow | -$124K | — |
| Financing Cash Flow | $8.7M | -11.6% |
| Free Cash Flow | -$7.9M | — |